ANL
Price
$1.47
Change
-$0.10 (-6.37%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
57.93M
14 days until earnings call
Intraday BUY SELL Signals
MOLN
Price
$4.19
Change
+$0.07 (+1.70%)
Updated
Nov 19, 04:13 PM (EDT)
Capitalization
155.6M
113 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANL vs MOLN

Header iconANL vs MOLN Comparison
Open Charts ANL vs MOLNBanner chart's image
Adlai Nortye
Price$1.47
Change-$0.10 (-6.37%)
Volume$368
Capitalization57.93M
Molecular Partners AG
Price$4.19
Change+$0.07 (+1.70%)
Volume$116
Capitalization155.6M
ANL vs MOLN Comparison Chart in %
ANL
Daily Signal:
Gain/Loss:
MOLN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANL vs. MOLN commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a Hold and MOLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ANL: $1.57 vs. MOLN: $4.12)
Brand notoriety: ANL and MOLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 3% vs. MOLN: 63%
Market capitalization -- ANL: $53.87M vs. MOLN: $159.91M
ANL [@Biotechnology] is valued at $53.87M. MOLN’s [@Biotechnology] market capitalization is $159.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 1 FA rating(s) are green whileMOLN’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 1 green, 4 red.
  • MOLN’s FA Score: 0 green, 5 red.
According to our system of comparison, MOLN is a better buy in the long-term than ANL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 5 TA indicator(s) are bullish while MOLN’s TA Score has 5 bullish TA indicator(s).

  • ANL’s TA Score: 5 bullish, 4 bearish.
  • MOLN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ANL and MOLN are a good buy in the short-term.

Price Growth

ANL (@Biotechnology) experienced а -3.09% price change this week, while MOLN (@Biotechnology) price change was +2.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

ANL is expected to report earnings on Dec 03, 2025.

MOLN is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MOLN($156M) has a higher market cap than ANL($57.9M). MOLN YTD gains are higher at: -13.227 vs. ANL (-41.531). ANL has higher annual earnings (EBITDA): -49.89M vs. MOLN (-58.01M). MOLN has more cash in the bank: 105M vs. ANL (98M). MOLN has less debt than ANL: MOLN (1.53M) vs ANL (39.5M). ANL has higher revenues than MOLN: ANL (5M) vs MOLN (0).
ANLMOLNANL / MOLN
Capitalization57.9M156M37%
EBITDA-49.89M-58.01M86%
Gain YTD-41.531-13.227314%
P/E RatioN/AN/A-
Revenue5M0-
Total Cash98M105M93%
Total Debt39.5M1.53M2,578%
TECHNICAL ANALYSIS
Technical Analysis
ANLMOLN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 7 days ago
68%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 9 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ANL
Daily Signal:
Gain/Loss:
MOLN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KEFI54.52N/A
N/A
Keweenaw Financial Corp.
PHIG32.00N/A
N/A
PHI Group, Inc (DE)
INRLF4.40N/A
N/A
Valneva SE
WPPGF3.62N/A
N/A
WPP PLC
CAJPY28.35-0.54
-1.87%
Canon, Inc.

ANL and

Correlation & Price change

A.I.dvisor tells us that ANL and FGHQF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANL and FGHQF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
N/A
FGHQF - ANL
25%
Poorly correlated
N/A
MOLN - ANL
23%
Poorly correlated
-3.29%
NVCT - ANL
21%
Poorly correlated
-0.33%
JAZZ - ANL
21%
Poorly correlated
+6.13%
VCEL - ANL
21%
Poorly correlated
-1.04%
More

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SNSE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
-3.29%
SNSE - MOLN
39%
Loosely correlated
+4.90%
SLDB - MOLN
36%
Loosely correlated
+3.00%
RCKT - MOLN
33%
Poorly correlated
-3.45%
ATRA - MOLN
31%
Poorly correlated
+2.71%
RAPT - MOLN
30%
Poorly correlated
-1.31%
More